By Megan Cheah
Medical- and surgical-product company Medline priced a secondary offering of 75 million shares at $41.00 each.
The shares will be sold by certain stockholders affiliated with private-equity giants Blackstone, Carlyle Group and Hellman & Friedman, as well as a wholly owned unit of the Abu Dhabi Investment Authority, Medline said Wednesday. The offering will raise $3.075 billion.
The selling stockholders have also granted the offering's underwriters a 30-day option to buy up to an additional 11.25 million class A common shares.
The offering is expected to close March 10.
Medline won't receive any proceeds from the share offering, it said. Goldman Sachs and Morgan Stanley are among banks advising on the deal.
The company listed on the Nasdaq in December, raising $6.26 billion in 2025's biggest IPO.
Write to Megan Cheah at megan.cheah@wsj.com
(END) Dow Jones Newswires
March 05, 2026 00:19 ET (05:19 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments